Human Leukocyte Antigen Testing Market,
Global Outlook and Forecast 2022-
2028 Market
Human Leukocyte Antigen Testing Market, Global Outlook and Forecast 2022-2028 Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Human Leukocyte Antigen Testing Market, Global Outlook and Forecast 2022-2028 Market Size and Growth
The global Human Leukocyte Antigen Testing Market is projected to reach a value of $1.2 billion by 2028, with a CAGR of 6.2% during the forecast period. This growth is attributed to increasing demand for organ transplants, advancements in HLA testing technology, and rising prevalence of autoimmune diseases. The market is expected to witness significant expansion due to the growing awareness about personalized medicine and increasing investments in healthcare infrastructure worldwide.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ F. Hoffman-La Roche
◍ Bio-Rad Laboratories
◍ QIAGEN N.V.
◍ Illumina
◍ Immucor
◍ CareDx
◍ Becton Dickinson
◍ Hologic
◍ GenDx
◍ Biofortuna
The competitive landscape of the Human Leukocyte Antigen Testing Market includes key players such as Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson, Hologic, GenDx, and Biofortuna. These companies provide advanced HLA testing solutions and contribute to the market growth.
- Thermo Fisher Scientific: $32.2 billion in 2021
- F. Hoffman-La Roche: $68.6 billion in 2021
- Bio-Rad Laboratories: $2.6 billion in 2021
Request Sample Report
Market Segmentation
By Application
◍ Independent Reference Laboratories
◍ Hospitals & Transplant Centers
◍ Research Laboratories & Academic Institutes
By Product
◍ Molecular Assay Technologies ◍ Non-molecular Assay Technologies
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
